Background Data regarding humoral and cellular response against SARS-CoV-2 in children
are scarce. We analysed seroconversion rate, decrease of anti-RBD IgG antibodies over …

Background The immunologic features of children with coronavirus disease 2019 (COVID-
19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are not …

Coronavirus disease 19 (COVID-19) is clinically less severe in children, even if the wide
variety and degree of severity of symptoms reported in children pose a still-unresolved …

Since the outbreak of SARS-CoV-2 among the population has occurred quite recently, there
is a lack of evidence on the long-term duration of antibody response, especially in children. It …

Importance The immune response in children with SARS-CoV-2 infection is not well
understood. Objective To compare seroconversion in nonhospitalized children and adults …

Objectives We aimed to study the outcomes, severity, and seroconversion post SARS-CoV-2
infection in immunocompromised children and adolescents treated at our center. Method For …

Importance The immune response in children with SARS-CoV-2 infection is not well
understood. Objective To compare seroconversion in children and adults with non …

Background Currently, more than 30,200,000 COVID-19 cases have been diagnosed in
Germany alone. However, data regarding prevalence of COVID-19 in children, both in …

Background SARS-CoV-2 infection in children does not seem to follow the same pattern as
in adults. Limited information is published on the level of antibody production and the …

Background Most children and youth develop mild or asymptomatic disease during severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, a very small …